Mr Yang has a wealth of experience in treating the full range of eye conditions. This includes common conditions such as dry eyes, glaucoma and blepharitis, as well as specific conditions such as macular degeneration and vitreous floaters.
In addition, Mr Yang has a special interest in cataracts and retinal conditions. He regularly performs normal and complex cataract surgery as well as retinal surgery. He is one of the few ophthalmologists who has trained in both the medical and surgical retinal disciplines and is experienced in treating all kinds of retinal conditions.
Keyhole cataract surgery enables accurate lens replacement. A variety of monofocal or multifocal lenses can be used to achieve spectacle-free vision.
INJECTION TREATMENT FOR AGE RELATED MACULAR DEGENERATION
Wet age related macular degeneration can be treated with anti VEGF agents (Lucentis, Eylea and Avastin). Treatment plans are personalised to each patient to achieve the best possible outcomes with minimum injections.
INJECTION TREATMENT FOR OTHER MACULAR CONDITIONS
Anti VEGF agents or steroid impregnated implants may be used to treat other macular conditions such as diabetic retinopathy, retinal vein occlusions, macular swelling and inflammation.
TREATMENT FOR VITREOUS FLOATERS
Floaters can be treated with laser techniques or surgery. A thorough assessment is conducted to determine the most appropriate course of action.
Vitrectomy surgery enables direct access to the retina at the back of the eye. This technique can be used to correct macular conditions such macular holes, epiretinal or macular membranes, vitreomacular traction and macular swelling.
RETINAL LASER AND SURGERY
Retinal conditions such as tears, holes, detachments or haemorrhage can be treated with laser, scleral buckling or vitrectomy surgery.
If cataracts occur in conjunction with other conditions such as macular, retinal or vitreous conditions, cataract surgery can be carried out at the same time as the macular, retinal or vitreous surgery to avoid the need for a second operation.